Fig. 1
From: Doxorubicin PK/PD modeling in multiple myeloma: towards in silico trials
Averaged data grouped by experiment. The 95% CI are represented by the gray areas. Data is presented with two different scales on the y-axes to better visualize the data in the experiments with \(\ge 50\) nM DOXO